PharmaShots | Incisive News in 3 Shots

Subscribe Now

$43M

Henlius Signs a License Agreement with Essex to Co-develop HLX04 (biosimilar- bevacizumab) for Ophthalmic Diseases

Henlius Signs a License Agreement with Essex to Co-develop HLX04 (biosimilar- bevacizumab) for Ophthalmic Diseases

October 19, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us